Clinical Trial Update: MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing mycophenolate mofetil against cyclophosphamide in induction therapy for pediatric active proliferative lupus nephritis; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Mycophenolate Mofetil, Cyclophosphamide | Phase 4 | Status: UNKNOWN